Acutus Medical, Inc. (AFIB) vs Nexalin Technology, Inc. (NXL)
- Acutus Medical, Inc. AFIB 0.00 NaN
- Nexalin Technology, Inc. NXL 2.35 −4.08%
Acutus Medical, Inc. and Nexalin Technology, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $2.6M against $1.7M — 1.5× the size. Acutus Medical, Inc. grew revenue faster over the last twelve months: 181.4% against 24.3%. Acutus Medical, Inc. has the higher net margin (−47.4% vs −4,138.5%) and the higher return on invested capital (−0.51% vs −1,108.8%). Across the 16 metrics below, Acutus Medical, Inc. leads on 14 and Nexalin Technology, Inc. on 2.
Valuation
Profitability
| Metric | AFIB | NXL | Medical Devices median |
|---|---|---|---|
| Gross margin | 5.03% | 86.14% | 56.01% |
| Operating margin | (0.28%) | (4,201.66%) | (15.03%) |
| Net margin | (47.36%) | (4,138.49%) | (20.40%) |
| Free cash flow margin | (157.62%) | (2,917.96%) | (7.24%) |
| Return on equity | 153.11% | (240.25%) | (15.32%) |
| Return on assets | (23.11%) | (187.89%) | (19.72%) |
| Return on invested capital | (0.51%) | (1,108.82%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack